Kiora Pharmaceuticals Investor Relations Material

Kiora Pharmaceuticals Inc is a U.S.-based clinical-stage biopharmaceutical company focused on developing treatments for ophthalmic diseases. The company’s pipeline includes therapies targeting eye conditions such as dry eye disease, retinal disorders, and ocular inflammation. Kiora develops both small molecules and biologics aimed at addressing unmet medical needs in vision care. The company conducts clinical trials and engages in research partnerships to advance its product candidates. Kiora Pharmaceuticals Inc is headquartered in Encinitas, California, and its shares are listed on the NASDAQ.